CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Cađ+ influx and RhoA/Rock pathway in VSMCs
Keyword(s): Â
Keyword(s): Â
Therapeutic Agent
â˝ Â
Renin Angiotensin System
â˝ Â
Peptide Hormone
â˝ Â
Experimental Models
â˝ Â
Electrolyte Balance
â˝ Â
Ang Ii
â˝ Â
Beneficial Effects
â˝ Â
Overwhelming Evidence
â˝ Â
Keyword(s): Â
Endothelial Cells
â˝ Â
Tissue Factor
â˝ Â
Plasminogen Activator
â˝ Â
Natriuretic Peptide
â˝ Â
Culture Media
â˝ Â
Tissue Type
â˝ Â
Dependent Manner
â˝ Â
Ang Ii
â˝ Â
Keyword(s): Â
2018 â˝ Â
Vol 25
(28)
â˝ Â
pp. 3333-3352
â˝ Â
Keyword(s): Â
Blood Pressure
â˝ Â
Central Nervous System
â˝ Â
Nervous System
â˝ Â
Therapeutic Potential
â˝ Â
Extensive Literature
â˝ Â
Ang Ii
â˝ Â
Mas Receptor
â˝ Â
Keyword(s): Â
Angiotensin Ii
â˝ Â
Renal Injury
â˝ Â
Critical Role
â˝ Â
Kidney Injury
â˝ Â
Renin Angiotensin System
â˝ Â
Tubular Cell
â˝ Â
Tubular Damage
â˝ Â
Renal Tubular Cell
â˝ Â
Ang Ii
â˝ Â
2019 â˝ Â
Vol 317
(6)
â˝ Â
pp. H1301-H1311
â˝ Â
Keyword(s): Â
Angiotensin Ii
â˝ Â
Cardiovascular Diseases
â˝ Â
Adhesion Molecules
â˝ Â
Vascular Endothelium
â˝ Â
Cardiac Remodeling
â˝ Â
Leukocyte Adhesion
â˝ Â
Neutralizing Antibody
â˝ Â
Ang Ii
â˝ Â
Cardiac Contractile
â˝ Â
Keyword(s): Â
Nitric Oxide
â˝ Â
Nitric Oxide Synthase
â˝ Â
Glomerular Filtration
â˝ Â
Renal Nerves
â˝ Â
Ang Ii
â˝ Â
Adrenergic Activity
â˝ Â
Single Nephron
â˝ Â
Synthase Inhibitor
â˝ Â
2021 â˝ Â
Vol 40
(4)
â˝ Â
pp. S532
Keyword(s): Â